Beau Schuyler is named as a lobbyist on federal disclosure filings for 25 clients through Thorn Run Partners and 1 other registrant. The most recent filing naming them posted in October 2026. Issues reported include Health Issues, Taxation/Internal Revenue Code, Medicare/Medicaid and Energy/Nuclear.
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| WINE AND SPIRITS WHOLESALERS OF AMERICA, INC. | THORN RUN PARTNERS | Q3 2026 | Agriculture, Taxation/Internal Revenue Code, Consumer Issues/Safety/Products |
| TALKIATRY MANAGEMENT SERVICES | THORN RUN PARTNERS | Q3 2026 | Health Issues |
| STERIS CORPORATION | THORN RUN PARTNERS | Q3 2026 | Environment/Superfund, Health Issues |
| SANOFI US SERVICES INC. | THORN RUN PARTNERS | Q3 2026 | Taxation/Internal Revenue Code, Medicare/Medicaid |
| PRUDENTIAL FINANCIAL, INC. | THORN RUN PARTNERS | Q3 2026 | Retirement, Taxation/Internal Revenue Code |
| PRINCIPAL FINANCIAL GROUP | THORN RUN PARTNERS | Q3 2026 | Financial Institutions/Investments/Securities, Retirement, Taxation/Internal Revenue Code |
| PHYSICIAN-LED HEALTHCARE FOR AMERICA | THORN RUN PARTNERS | Q3 2026 | Medical/Disease Research/Clinical Labs, Health Issues |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | THORN RUN PARTNERS | Q3 2026 | Health Issues |
| OTSUKA AMERICA PHARMACEUTICAL, INC. | THORN RUN PARTNERS | Q3 2026 | Taxation/Internal Revenue Code, Pharmacy, Health Issues |
| NW NATURAL HOLDING COMPANY | THORN RUN PARTNERS | Q3 2026 | Taxation/Internal Revenue Code, Energy/Nuclear |
| INSTITUTE FOR GENE THERAPIES | THORN RUN PARTNERS | Q3 2026 | Health Issues |
| GLAUKOS CORPORATION | THORN RUN PARTNERS | Q3 2026 | Taxation/Internal Revenue Code, Medicare/Medicaid, Health Issues |
| FIRST SOLAR, INC. | THORN RUN PARTNERS | Q3 2026 | Energy/Nuclear |
| FINANCIAL SERVICES INSTITUTE | THORN RUN PARTNERS | Q3 2026 | Financial Institutions/Investments/Securities, Taxation/Internal Revenue Code, Labor Issues/Antitrust/Workplace |
| BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. | THORN RUN PARTNERS | Q3 2026 | Health Issues |
| ARDELYX, INC. | THORN RUN PARTNERS | Q3 2026 | Health Issues |
| AMERIHEALTH CARITAS | THORN RUN PARTNERS | Q3 2026 | Medicare/Medicaid, Health Issues |
| AMERICAN SENIORS HOUSING ASSOCIATION | THORN RUN PARTNERS | Q3 2026 | Health Issues, Immigration, Housing |
| AMERICAN POLICY VENTURES ACTION | THORN RUN PARTNERS | Q3 2026 | Science/Technology, Energy/Nuclear, Government Issues |
| ALTRIA CLIENT SERVICES, LLC | THORN RUN PARTNERS | Q3 2026 | Tobacco, Taxation/Internal Revenue Code |
| ALLIANCE TO SAVE AMERICA'S 340B PROGRAM (ASAP 340B) | THORN RUN PARTNERS | Q3 2026 | Medicare/Medicaid |
| GLAXOSMITHKLINE LLC | THORN RUN PARTNERS | Q4 2025 | Health Issues |
| BORGWARNER INC. | THORN RUN PARTNERS | Q4 2025 | Taxation/Internal Revenue Code, Automotive Industry, Manufacturing |
| MEDLINE INDUSTRIES, LP | THORN RUN PARTNERS | Q2 2025 | Trade (domestic/foreign), Health Issues |
| ARDELYX, INC. | ARDELYX, INC. | Q1 2025 | Health Issues |
| BRIDGEBIO PHARMA, INC. | THORN RUN PARTNERS | Q1 2025 | Medicare/Medicaid, Health Issues |
| Year | Clients | Registrants |
|---|---|---|
| 2026 | 21 | 1 |
| 2025 | 21 | 2 |
| Year | Items | Total |
|---|---|---|
| 2026 | 16 | $24K |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Beau Schuyler. See the Capitol Clarity rankings and method.